Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-04-23

Clinical Trial Update: Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure [NA]

View source ↗

Summary

Recruitment is underway for a Barostim-enabled neurohormonal intervention intended to improve treatment of heart failure. The conditions include heart failure w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Barostim

Snippet

Sponsor: CVRx, Inc. | Conditions: Heart Failure, Heart Failure NYHA Class II | NA | Status: RECRUITING